We already have good efficacy data with the most extremely sick and poor OS rate of patients one can imagine. Even the standard care to increase OS by just 9 months only works for one third of the patients. The bar of success in terms of OS is set very low for us and even the charity case of Josei Dunn has highlighted the drug is proving itself to at least one father and scientist it ture value. How does one value an extend life and especially that of a child?
and remember as a combination treatment value only increases as it is the case now with radiotherapy being tried
- Forums
- ASX - By Stock
- KZA Media Thread
We already have good efficacy data with the most extremely sick...
-
- There are more pages in this discussion • 1,940 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review